Genocea Biosciences Inc (GNCA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genocea Biosciences Inc (GNCA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH141232D
  • |
  • Pages: 57
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Genocea Biosciences Inc (Genocea), formerly GenoceaInc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas technology uses a cellular assay to comprehensively re-create a patient's actual immune response to cancer. The company's Gen-009 cancer vaccines are being designed to educate T cells to recognize and attack specific targets and thereby kill cancers. It offers pre-clinical and clinical investigational immunotherapies. The compnay's partnership program includes antigen discovery, immune responsw profiling, Gen-003 for general herpes and other disease programs.Genocea is headquartered in Cambridge, Massachusetts, the US.

Genocea Biosciences Inc (GNCA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note : Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Genocea Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Genocea Biosciences Secures Funds from Hercules Technology 12

Genocea Biosciences Secures USD16.09 Million in Venture Funding from Auriga Partners 13

Genocea Biosciences Raises USD 0.4 Million In Venture Financing 14

Genocea Biosciences Raises USD 30 Million In Series C Financing 15

Partnerships 17

Genocea Biosciences Enters into Research Agreement with Checkmate Pharma 17

Genocea Biosciences Enters into Agreement with US Oncology Research 18

Genocea Biosciences Enters into Agreement with Memorial Sloan Kettering Cancer Center 19

Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School 20

Licensing Agreements 21

Genocea Biosciences Enters into Licensing Agreement with Oncovir 21

Equity Offering 22

Genocea Biosciences to Raise up to USD23.3 Million in Public Offering of Shares 22

Genocea Biosciences Raises USD53.4 Million in Public Offering of Shares 23

Genocea Biosciences Raises USD1.6 Million in Public Offering of Preferred Shares 25

Genocea Biosciences Raises USD50 Million in Public Offering of Shares 27

Genocea Biosciences Raises USD52 Million in Public Offering of Shares 29

Genocea Biosciences Raises USD2 Million in Private Placement of Shares 31

Genocea Biosciences Withdraws Public Offering of Shares 33

Genocea Biosciences Completes IPO For USD 66 Million 34

Genocea Biosciences Inc-Key Competitors 36

Genocea Biosciences Inc-Key Employees 37

Genocea Biosciences Inc-Locations And Subsidiaries 38

Head Office 38

Recent Developments 39

Financial Announcements 39

Aug 02, 2018: Genocea reports second quarter 2018 financial and operating results 39

May 10, 2018: Genocea Reports First Quarter 2018 Financial and Operating Results 40

Feb 15, 2018: Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results 41

Nov 02, 2017: Genocea Reports Third Quarter 2017 Financial Results 43

Aug 09, 2017: Genocea Biosciences Reports Second Quarter 2017 Financial Results 45

May 04, 2017: Genocea Reports First Quarter 2017 Financial Results 46

May 04, 2017: Genocea Biosciences Q1 net loss increases 47

Feb 16, 2017: Genocea Reports Fourth Quarter and Year-End 2016 Financial Results 48

Corporate Communications 50

Mar 12, 2018: Genocea Appoints Narinder Singh as SVP Pharmaceutical Sciences & Manufacturing 50

Feb 12, 2018: Genocea Biosciences Names Ali Behbahani, M.D., As Board Director 51

Mar 06, 2017: Howard Mayer, M.D., of Shire, Joins Genocea Biosciences' Board of Directors 52

Product News 53

09/25/2017: Genocea Announces Strategic Shift to Immuno-oncology and the Development of Neoantigen Cancer Vaccine GEN-009 53

04/18/2018: Genocea Presents Data at AACR Annual Meeting Further Highlighting Advantages of ATLAS Platform in Identification of Neoantigens over in silico Methods 54

04/09/2018: Genocea to Present Data at Upcoming AACR Annual Meeting Further Highlighting ATLAS Platform Ability to Identify and Characterize Neoantigens for Cancer Vaccines 55

Product Approvals 56

Apr 30, 2018: Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009 56

Appendix 57

Methodology 57

About GlobalData 57

Contact Us 57

Disclaimer 57

List of Figures

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

List of Tables

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Genocea Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Genocea Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Genocea Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Genocea Biosciences Secures Funds from Hercules Technology 12

Genocea Biosciences Secures USD16.09 Million in Venture Funding from Auriga Partners 13

Genocea Biosciences Raises USD 0.4 Million In Venture Financing 14

Genocea Biosciences Raises USD 30 Million In Series C Financing 15

Genocea Biosciences Enters into Research Agreement with Checkmate Pharma 17

Genocea Biosciences Enters into Agreement with US Oncology Research 18

Genocea Biosciences Enters into Agreement with Memorial Sloan Kettering Cancer Center 19

Genocea Biosciences Enters Into Research Agreement With Dana-Farber Cancer Institute And Harvard Medical School 20

Genocea Biosciences Enters into Licensing Agreement with Oncovir 21

Genocea Biosciences to Raise up to USD23.3 Million in Public Offering of Shares 22

Genocea Biosciences Raises USD53.4 Million in Public Offering of Shares 23

Genocea Biosciences Raises USD1.6 Million in Public Offering of Preferred Shares 25

Genocea Biosciences Raises USD50 Million in Public Offering of Shares 27

Genocea Biosciences Raises USD52 Million in Public Offering of Shares 29

Genocea Biosciences Raises USD2 Million in Private Placement of Shares 31

Genocea Biosciences Withdraws Public Offering of Shares 33

Genocea Biosciences Completes IPO For USD 66 Million 34

Genocea Biosciences Inc, Key Competitors 36

Genocea Biosciences Inc, Key Employees 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Genocea Biosciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 18130
Site License
USD 500 INR 36260
Corporate User License
USD 750 INR 54390

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com